Clinical Site Reactivation Amid COVID-19: The Patient Perspective
In May 2020, Syneos Health hosted a panel discussion and Q&A session with three US Principal Investigators. Together, we discussed considerations for clinical trial sites as they continue ongoing activities & plan to restart trials in light of the COVID-19 pandemic.
In this video, Clare Grace sheds light on pressing inquiries about reengaging patients, including:
- Sites’ biggest concerns
- Varied responses from large & small pharma
- Impact on patient attrition
- Patient views and reactions to site visits
- Putting patient safety first
This video is part of a two-part series on Clinical Site Reactivation, highlighting the clinical sites’ experience with patient interactions and offering suggestions for sponsors.
The Clinical Site Reactivation series is part of Syneos Health Insights Hub Live. Syneos Health Insights Hub Live uncovers unique insights and global trends discovered by experts working on the front lines of healthcare around the world. How do we change lives? Watch and learn.
Next Article in the Series
Looking for exclusive insight?
